-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Ambrx Biopharma Cayman, Inc. quarterly/annual Depreciation history and growth rate from Q2 2022 to Q2 2023.
- Ambrx Biopharma Cayman, Inc. Depreciation for the quarter ending June 30, 2023 was $200K, unchanged year-over-year.
- Ambrx Biopharma Cayman, Inc. annual Depreciation for 2022 was $800K, a 33.3% increase from 2021.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)